Paracoccidioidomycosis (PCM) is a systemic mycosis with occurrence restricted to South and Central America, being rural residents the largest affected group. The diagnosis of PCM has traditionally relied on the finding of characteristic yeast forms on direct examination, culture, or histopathology (Lacaz 1994) . Serological tests such as double immunodifusion and counter-immunoelectrophoresis are also employed for the diagnosis and follow-up of this mycosis (Mendes-Giannini et al. 1994) , as well as the detection of a 43-kDa glycoprotein exoantigen (gp43) (Silva et al. 2004) .
Studies with blood, cerebrospinal fluid, and sputum specimens from patients with different fungal infections indicated that the polymerase chain reaction (PCR) assay is more sensitive in diagnosing invasive fungal infections than culture methods (Reiss et al. 1998) . While several PCR systems have been described, reports on clinical samples from PCM patients are rare. In a study employing sputa specimens, Paracoccidioides brasiliensis DNA was detected by gp43-PCR in 100% (11/11) of patients with Xray proven, pulmonary infection (Gomes et al. 2000) . Goldani and Sugar (1998) used primers from a P. brasiliensis specific sequence spanning a 62 bp fragment, and were able to show its presence in sera of 5/5 experimentally infected mice. Bialek et al. (2000) developed a highly sensitive and specific nested-PCR detecting a fragment from the gp43 gene on lung homogenates from infected animals and in human tissue samples.
Our objective was to evaluate the use of PCR for detection of P. brasiliensis DNA on sera samples from untreated patients with direct evidence of PCM and differ-ent clinical forms. This study was approved by the Ethics Committee of the Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo.
Thirty-three serum samples from patients with PCM (Table) were submitted to nested-PCR with primers spanning a 196 bp fragment from the gp43 gene as described by Bialek et al. (2000) . P. brasiliensis genome contains two copies of the gp43 gene (Cano et al. 1998 ). Amplification of a fragment of 432 bp from the human growth hormone gene was used as a positive control for the whole process according to Meyer et al. (1999) . Among the 33 serum samples analyzed, 25 had the HGH fragment amplified, demonstrated DNA adequacy. When DNAs were submitted to the gp43 nested-PCR assay, only one presented the expected amplified fragment. Moreover, all 33 serum samples, when spiked with P. brasiliensis cells, presented the corresponding gp43 amplicon, discarding major PCR inhibition. Our results suggest that PCR with DNA extracted from serum, is not useful for the diagnosis of PCM, due to the low prevalence of fungemia in patients with different clinical forms of untreated paracoccidiodomycosis. Itano et al. (2002) were able to show PCR detection of P. brasiliensis DNA on 5/20 infected patients with DNA isolated from serum. However these results were obtained only after a third-round of PCR and they obtained no amplification on plasma samples from 78 infected mice after two-rounds of amplification (nested-PCR). An interesting observation of this work was a much higher frequency of positive PCR amplification with DNA extracted from clots in comparison to plasma.
In conclusion, our results show a limited value of nested PCR from serum samples, at least on its present form, for the identification of P. brasiliensis DNA. Though disappointing, the low detection rate here reported is corroborated by similar results from heavily infected experimental animals and also from the observation of the rarity of P. brasiliensis fungemia and isolation on blood culture from patients and infected mice (Singer-Vermes et al. 1993 ). Absence of P. brasiliensis DNA in sera of PCM patients deserves further investigation, as it contrasts to other deep mycosis. One possibility is that fungal DNA and/or cells are rapidly fagocytosed by leukocytes, reinforced by a recent observation showing that P. brasiliensis cells are readily detected and quantified in the bloodstream of experimental animals by staining with a fluorescence dye (Nishikaku & Burger 2003) . We plan to carry a parallel comparison between whole blood and plasma/serum in order to clarify this issue. 
